What is Radialogica?
Radialogica operates at the intersection of oncology and digital health, providing sophisticated software solutions designed to enhance the safety and efficacy of radiation therapy. By offering comprehensive quality management tools for both clinical practice and large-scale clinical trials, the company addresses the critical need for standardized, high-precision care in cancer treatment. Their platform serves as a vital bridge between clinical providers, pharmaceutical innovators, and medical device manufacturers, ensuring that radiation therapy protocols are executed with maximum accuracy.
With a footprint spanning over 225 clinical sites globally, Radialogica has successfully integrated its technology into the workflows of major healthcare institutions. The company's focus on reducing the burden of cancer survivorship through data-driven insights positions it as a key player in the global oncology market, where the demand for automated quality assurance and patient-centric software continues to accelerate.
How much funding has Radialogica raised?
Radialogica has raised a total of $4.7M across 4 funding rounds:
Private Equity
$1.3M
Private Equity
$2.9M
Debt
$150K
Debt
$343K
Private Equity (2013): $1.3M, investors not publicly disclosed
Private Equity (2016): $2.9M, investors not publicly disclosed
Debt (2020): $150K supported by PPP
Debt (2021): $343K featuring PPP
Key Investors in Radialogica
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Radialogica?
With the recent influx of capital, Radialogica is well-positioned to expand its global reach and deepen its integration within the pharmaceutical and biotech research ecosystems. The strategic roadmap likely involves scaling its quality assurance programs to support more complex clinical trials and enhancing its software suite to incorporate advanced predictive analytics. As the company moves into this next phase of growth, the focus will remain on leveraging its existing data infrastructure to drive innovation in radiation oncology, ultimately aiming to set new benchmarks for patient safety and treatment efficacy on a global scale.
See full Radialogica company page
